Expertise in
4
conditions

Theo M. De Reijke

Amsterdam, NH, NL 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
4
conditions
Amsterdam, NH, NL 

Overview

Theo De Reijke practices practicing medicine in Amsterdam, Netherlands.

De Reijke is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Prostate Cancer, Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Prostatectomy, and Endoscopy.

They are actively involved in clinical research, co-authoring 66 peer reviewed articles and participating in 2 clinical trials.

Locations

Amsterdam, NH, Netherlands
Other Locations
Arnhem, GE, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer
Phase II Study of Oral Metformin for Intravesical Treatment of Non-muscle-invasive Bladder Cancer
Enrollment Status: Recruiting
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Metformin
Study Phase: Phase 2
Evaluation of the Xpert® Bladder Cancer Monitor Assay Compared to Cystoscopy for the Follow-up of Patients With History of Low or Intermediate Risk Non-muscle-invasive Bladder Cancer (NMIBC): an Observational Prospective International Multicenter Study
Evaluation of the Xpert® Bladder Cancer Monitor Assay Compared to Cystoscopy for the Follow-up of Patients With History of Low or Intermediate Risk Non-muscle-invasive Bladder Cancer (NMIBC): an Observational Prospective International Multicenter Study
Enrollment Status: Completed
Publish Date: February 13, 2023
Intervention Type: Diagnostic test
View 1 Less Clinical Trial

66 Total Publications

Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis.
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer: A Meta-Analysis.
Journal: JAMA oncology
Published: November 20, 2025

Frequently Asked Questions about Theo M. De Reijke

Is Theo M. De Reijke a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Theo M. De Reijke is classified as an Distinguished expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Theo M. De Reijke participate in research or clinical trials?

Yes. Theo M. De Reijke has published 66 articles and abstracts on conditions like Prostate Cancer. You can view a list of Theo M. De Reijke's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find De Reijke's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile